KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.85

A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center.

Lisa Cuba, Pauline Dürr, Katja Gessner, Babette Häcker, Rainer Fietkau, Jürgen Siebler, Marianne Pavel, Markus F Neurath, Carola Berking, Bernd Wullich, Valeska Brückl, Matthias W Beckmann, Martin F Fromm, Frank Dörje

JCO Oncol Pract 20(9) 1219-1230

PMID38848539
PMCID-
DOI10.1200/OP.23.00694
发表日期2024-06-07
入排依据:The study is an implementation science trial focused on medication safety with oral antitumor therapy. While it is an oncology, human, randomized, Phase III trial with a drug intervention and reports original results, it lacks a primary or key secondary time-to-event efficacy endpoint (e.g., OS, PFS). Its primary endpoint is an implementation outcome (percentage of patients counseled).
摘要

摘要

PURPOSE: Implementation science endeavors to facilitate the translation of evidence-based research into clinical routine. The clinical pharmacological/pharmaceutical care program evaluated in the randomized AMBORA trial on medication safety with oral antitumor therapeutics (OAT) optimizes care delivery and provides significant benefits for patients, treatment teams, and health care systems. Thus, we aimed to investigate the implementation of this care program within the AMBORA Competence and Consultation Center (AMBORA Center). METHODS: The AMBORA Center within a University Comprehensive Cancer Center offered several services (eg, patient consultations) and was evaluated according to the RE-AIM framework. This multicenter hybrid type III trial focused on implementation outcomes (eg, patient recruitment, referring units, evaluation of services) while concurrently investigating effectiveness (eg, side effects, medication errors). Quantitative and qualitative assessments were combined. RESULTS: The AMBORA Center conducted over 800 consultations with 420 patients in seven institutions. The primary end point of counseling 70% of patients treated with OAT was not reached. Patients were referred by 15 treatment units compared with 11 units in the AMBORA trial. On the basis of heterogeneous referral rates and characteristics across the institutions, barriers and facilitators of the implementation process were derived. Several survey results (eg, stakeholder interviews, online/paper-based questionnaires) reflected a high appreciation of services by patients and health care professionals. The severity of 60.1% (178 of 296) of detected side effects improved, and 86.3% (297 of 344) of medication errors were resolved. CONCLUSION: Despite not reaching the primary implementation outcome, the AMBORA Center included more treatment units and demonstrated patient benefit of the AMBORA care program by meeting all effectiveness outcomes. We outlined quantitative and qualitative implementation characteristics to enhance outreach and foster further dissemination of centers to optimize medication safety with OAT.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。